ReWalk Robotics prices its initial public offering at $12 a share, under its prior range, raising $36 million for its exoskeleton for spinal cord injury patients
ReWalk Robotics (NSDQ:RWLK) priced its initial public offering below its forecast range, at $12 per share, grossing some $36.0 million for its exo-skeleton suit.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1D0kr3a
Cap comentari:
Publica un comentari a l'entrada